Staff Scientist

Conclusions: This study shows that 68Ga-Galmydar has the potential to provide noninvasive and early assessment of chemotherapy-related myocardial metabolic changes, and lays the foundation for further assessment of 68Ga-Galmydar in large animal models of chemocardiotoxicity and translation in to human subjects. References: Sivapackiam, J., et al., PlosOne., 2019,14, e0215579. Funding: NIH R01 HL142297, R01 HL111163

Source: Journal of Nuclear Medicine - May 14, 2020 Category: Nuclear Medicine Authors: Sivapackiam, J., Leon, L., Knernschield, J., Kabra, S., Fox, G., Rettig, M., Woodard, P., Weilbaecher, K., Sharma, V. Tags: Tech Papers V: Cardiovascular Science & amp; Neuroscience Technologist Papers Source Type: research